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A b s t r a c t
In variant Creutzfeldt-Jakob disease (vCJD), a disease linked to bovine spongiform encephalopathy (BSE), florid-type
prion protein (PrPsc) deposits are aggregated around the larger diameter (> 10 µm) cerebral microvessels. Clustering
of PrPsc deposits around blood vessels may result from blood-borne prions or be a consequence of the cerebral vas-
culature influencing the development of the florid deposits. To clarify the factors involved, the dispersion of the florid
PrPsc deposits was studied around the larger diameter microvessels in the neocortex, hippocampus, and cerebellum
of ten cases of vCJD. In the majority of brain regions, florid deposits were clustered around the larger diameter ves-
sels with a mean cluster size of between 50 µm and 628 µm. With the exception of the molecular layer of the den-
tate gyrus, the density of the florid deposits declined as a negative exponential function of distance from a blood ves-
sel profile suggesting that diffusion of molecules from blood vessels is a factor in the formation of the florid deposits.
Diffusion of PrPsc directly into the brain via the microvasculature has been demonstrated in vCJD in a small number
of cases. However, the distribution of the prion deposits in vCJD is more likely to reflect molecular ‘chaperones’ dif-
fusing from vessels and promoting the aggregation of pre-existing PrPsc in the vicinity of the vessels to form florid
deposits.
Key words: variant Creutzfeldt-Jakob disease (vCJD), disease form of prion protein (PrPsc), florid deposits, clustering,
diffusion, negative exponential model.
Communicating author: 
R.A. Armstrong, Vision Sciences, Aston University, Birmingham, B4 7ET, UK, phone 0121-359-3611, fax 0121-333-4220, 
e-mail: R.A.Armstrong@aston.ac.uk
Original article
Introduction
Four subtypes of Creutzfeldt-Jakob disease (CJD)
have been described to date, viz., genetic or familial
CJD (fCJD) [18], iatrogenic CJD (iCJD), resulting from
the direct transmission of PrPsc, sporadic CJD (sCJD)
[11,40], and variant CJD (vCJD) [43]. Variant CJD is the
most recent subtype to be described and was first
reported in the United Kingdom (UK) in 1996 [43]. 
The majority of vCJD patients initially develop psychi-
atric symptoms such as depression and/or anxiety,
and these symptoms are usually followed by ataxia,
involuntary movements, and cognitive impairment.
Most patients affected to date are young (median age
28 years, range 14-74 years) and death occurs within
12-24 months; a significantly longer duration than
observed in the more common sCJD [43].
How the majority of CJD cases acquire the disease
form of prion protein (PrPsc) is uncertain. Variant CJD
has been linked to the consumption of beef originat-
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ing from cattle with bovine spongiform encephalopa-
thy (BSE) [43]. BSE can be transmitted to sheep by
transfusing them with whole blood from another
sheep during symptom free exposure to BSE [22]. In
addition, although PrPsc has not been found in human
serum [15], normal prion protein (PrP) is present in
human blood [31]. However, there is a theoretical risk
of secondary vCJD transmission from human to
human via blood and blood products, organs and tis-
sues or via contaminated surgical instruments and
medical devices. This concern has resulted in the
blood transfusion service in the UK implementing uni-
versal leucodepletion of cellular blood components to
minimize the possible risk [16,35]. Moreover, four cas-
es of probable vCJD transmission via the blood have
now been described and one further case of second-
ary infection via a plasma product [12]. 
Two morphological types of PrPsc deposit com-
monly occur in the brains of individuals with vCJD [9].
First, ‘florid’ deposits comprise a condensed ‘core’ of
PrPsc and are heavily stained with antibodies raised
against PrP [29,39]. Second, diffuse deposits (also
called ‘fine feathery diffuse deposits’ or ‘fine diffuse
plaques’) are more lightly stained and irregular in
shape and lack a condensed core [3,32]. A previous
study demonstrated a positive spatial correlation
between the florid deposits and the cerebral
microvessels in vCJD suggesting that prions may
spread into the brain via the cerebral microcirculation
[10]. In sCJD, the synaptic-type PrPsc deposits were
also aggregated around blood vessels [7]. 
A number of hypotheses could account for the dis-
tribution of the florid deposits around blood vessels in
vCJD. First, blood-borne prions could enter the brain
via the cerebral circulation and diffuse from the ves-
sels into the neuropil. Second, the distribution could
represent an abortive attempt to clear PrPsc from the
brain [42]. Third, florid deposits could develop from
PrP originating from the endothelia of blood vessels
or associated cells [38]. Fourth, proteins acting as
‘molecular chaperones’, could diffuse into the brain
from the cerebral circulation and influence the deve -
lopment of PrPsc deposits adjacent to the vessels [7,8].
To clarify the factors involved, the present study test-
ed the hypothesis that diffusion from blood vessels
could be involved in the formation of the florid
deposits. First, the spatial pattern of the florid
deposits around the larger diameter-blood vessel pro-
files was studied in regions of the cerebral cortex, hip-
pocampus, and cerebellum. Second, a mathematical
model was fitted to the data which predicts the dis-
tribution of the florid deposits around a blood vessel
that would result from diffusion [5].
Material and methods
Cases
Ten cases of vCJD (details in Table I), all fulfilling
the criteria for a pathological diagnosis of vCJD [24],
were obtained from the National CJD Surveillance
Unit, Western General Hospital, Edinburgh, UK. The
principles embodied in the 1975 Helsinki declaration
(as modified Edinburgh, 2000) were followed with
respect to experiments involving material of human
origin. None of the vCJD cases had any of the known
mutations of the PrP gene or family history of prion
disease, and there was no evidence of the known
types of iatrogenic aetiology. The pattern of PrPsc de -
position typical of vCJD was observed in all cases with
florid-type deposits in the cerebral cortex, cerebellum,
basal ganglia, thalamus, and brain stem [23].
Preparation of material
Blocks of the frontal cortex (FC) (B8) at the level of
the genus of the corpus callosum, parietal cortex (PC)
(B7) at the level of the splenium of the corpus callo-
sum, occipital cortex (OC) including the calcarine sul-
cus (B17), and temporal cortex at the level of the late -
ral geniculate body were taken from each brain.
Within the temporal lobe, the inferior temporal gyrus
(ITG) (B22) and parahippocampal gyrus (PHG) (B28)
were studied.  In addition, a block of the right cerebel-
lar cortex was taken from each case at the level of the
superior cerebellar peduncle. Tissue was fixed in 10%
phosphate buffered formal-saline and embedded in
paraffin wax. For quantitative analysis, coronal 7 µm
sections were immunolabelled using the monoclonal
antibody 12F10 (dilution 1 : 250) which binds to a re -
gion of human PrP downstream of the neurotoxic
domain adjacent to helix region 2: residues 142-160
[28] (kindly provided by Prof. G. Hunsmann, The Ger-
man Primate Centre, Gottingen, Germany). Immu -
noreactivity was enhanced by formic acid (98% for
50 minutes) and autoclaving (121°C for 10 minutes)
pretreatment [20]. Sections were treated with Dako
Biotinylated Rabbit anti-Mouse (RAM) (dilution 1 : 100)
and Dako ABComplex HRP kit for 45 minutes (Amer-
sham, UK). Diaminobenzidine tetrahydrochloride was
used as the chromogen. Immunolabelled sections
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were also stained with haematoxylin for 1 minute to
reveal the blood vessel profiles.
Morphological methods
In the cerebral cortex, the density of the florid
deposits, and the incidence of blood vessels was
measured parallel to the pia mater along strips of tis-
sue (3200 to 6400 µm in length) using 50 × 250 µm
contiguous sample fields. A micrometer eyepiece with
100 horizontal divisions was used as the sample field.
The sample fields were located within cortical laminae
II/III and V/VI, the short edge of the field being aligned
with guidelines marked on the slide and located par-
allel to the pia mater. In the hippocampus, measure-
ments commenced at the beginning of CA1 and
extended as far as the CA2/CA3 boundary; the short
dimension of the sample field being aligned with the
alveus. In the dentate gyrus, the sample fields were
aligned with the top of the granule cell layer. In the
cerebellum, the short edge of the sample field was
aligned with the edge of the section to sample the
outer region of the molecular layer. Florid deposits
(Fig. 1) are easily distinguishable from diffuse deposits
and consist of a condensed ‘core’ of PrPsc surrounded
by a peripheral ring of small vacuoles. All blood vessel
profiles visible in the section were sampled. The vessel
profiles were quantified by ‘lattice sampling’, i.e., by
Case Gender Age at onset Duration Brain weight  Atrophy
(yrs) (yrs) (gm)
A F 39 2 586L None
B F 28 1 1375 None
C F 28 1 NA NA
D M 19 1 NA NA
E M 30 1 699R None
F M 48 2 1470 None
G F 34 1 810L None
H M 18 1 1434 None
I M 24 1 NA NA
J F 21 2 1394 None
Table I. Demographic data and gross brain details of the variant Creutzfeldt-Jakob disease (vCJD) cases. 
M – male, F – female, R – right hemisphere only, L – left hemisphere only, NA – data not available
Fig. 1. Cluster of florid PrPsc deposits surround-
ing a larger diameter blood vessel (BV) in the
superior frontal cortex of a patient with variant
Creutzfeldt-Jakob disease (vCJD) (magnification
bar = 30  µm).
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counting the number of times the intersections of the
grid lines encountered a vessel [3]. 
Correlations between the densities of the florid
deposits and the frequency of contacts with blood
vessels were tested for each brain region using Pear-
son’s correlation coefficient r. The degree of correla-
tion between the abundance of two histological fea-
tures depends on field size [4]. Hence, to determine
the scale at which the correlation was evident, counts
of histological features in adjacent sample fields were
added together successively to provide data for
increasing field sizes, e.g., 50 × 250 µm (field size 1),
100 × 250 µm (field size 2), 200 × 250 µm (field size 3)
etc., up to a size limited by the length of the strip
sampled. Pearson’s r was calculated for each field size
and the change in r with field size examined for each
brain region. Hence, significant correlations at the
smallest field sizes (50 µm, 100 µm) suggest a close
spatial relationship between PrPsc deposits and blood
vessels. By contrast, a significant correlation present
at a larger field size only is likely to reflect the gene ral
abundance of florid deposits and blood vessels in the
section [27,30]. The dimension of the florid plaque
clusters in each tissue was estimated using spatial
pattern analysis [2,6].
Dispersion of florid plaques around 
blood vessels
Transient or local leakage of proteins from blood
vessels is likely to have a diminishing effect with dis-
tance from a blood vessel. Mathematically, randomly
diffusing particles from a point source will result in
a spatial distribution of particles which declines as
a negative exponential function of distance from the
source [37]. Hence, the distribution of the florid
deposits was studied at different distances from
a sample of prominent blood vessel profiles [5]. A sam-
ple of the larger vessel profiles was selected from
each region from each vCJD case. Each blood vessel
profile fulfilled the following criteria: 1) florid deposits
were present around the selected vessel, 2) the vessel
diameter was at least 10 µm measured parallel to the
pia mater, and 3) the vessel profile was separated, at
least on one side, by a distance of at least 2200 µm
from the nearest large blood vessel. The number of
florid deposits was then counted at different dis-
tances from each vessel in seven, 50 × 250 µm verti-
cally oriented, contiguous sample fields with the
short edge parallel with the pia mater. At least 10
blood vessels were studied from each brain region
and a negative exponential model fitted to the com-
bined data. The simplest type of exponential model
was fitted to the data in which the number of florid
deposits (Y) was assumed to decline as a negative
exponential function of distance (X) from the blood
vessel, i.e., Y = a(exp-bx) [5,37]. To fit this model: 1) an
exponential function was fitted to the original data
and 2) a linear function was fitted to the logarithm
(Log) of the density of the florid deposits plotted
against distance from the source [40].
Results
Figure 1 shows a vertically penetrating arteriole in
the upper laminae of the frontal cortex surrounded
by florid PrPsc deposits. The florid deposits are clearly
aggregated around the vessel profile; while the diffuse
PrPsc deposits are less frequent close to the vessel.
The estimated dimensions of the clusters of the
florid PrPsc deposits and the spatial correlations
between the densities of the florid deposits and the
larger diameter blood vessels are summarized in
Table II. The mean cluster size of the florid deposits
varied from 50 µm to 628 µm; the largest clusters of
deposits being present in the occipital cortex and the
smallest in sectors CA1/2 of the hippocampus, and in
the molecular layer of the dentate gyrus. In neocorti-
cal regions, the percentage of cases in which a signi -
ficant positive correlation between the florid deposits
and blood vessels was present varied from 70% to
90%. Correlations between the florid deposits and the
blood vessels were observed less consistently in the
hippocampus and cerebellum. 
The relationship between the density of florid
deposits and distance from the larger diameter blood
vessels is shown for a single brain region (Frontal cor-
tex, laminae V/VI) in Fig. 2. The untransformed densi-
ties show that the florid deposits declined rapidly with
distance from a vessel. In addition, the density of the
florid deposits, expressed on a logarithmic scale,
declined linearly with distance from the blood vessels
(r = 0.97, P < 0.001) consistent with a negative expo-
nential model. The data for all brain regions is sum-
marised in Table III. The relationship between the loga -
rithm of density of the florid deposits and distance
from the blood vessels was fitted successfully by
a negative exponential model in all regions examined
with the exception of the molecular layer of the den-
tate gyrus.
vCJD pathology and blood vessels
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Table II. Mean cluster sizes of the florid prion protein (PrPsc) deposits and the spatial correlation (Pearson’s r)
with larger diameter (> 10 µm) blood vessel profiles in various brain regions.
Size data preceded by ≥ indicate large scale clustering of PrPsc deposits of at least 1600 µm. Data not preceded by ≥ indicate clusters that are regularly dis-
tributed parallel to the pia mater. (–) density of florid PrPsc deposits too low to determine spatial patterns, R – random distribution, Reg – regular distribution
SFC – superior frontal cortex, PC – parietal cortex, OC – occipital cortex, ITG – inferior temporal gyrus, PHG – parahippocampal gyrus, HC – hippocampus sec-
tors CA1/2, DG – dentate gyrus, CB – molecular layer of the cerebellum in 10 cases of variant Creutzfeldt-Jakob disease (vCJD) 
*P < 0.05, **P < 0.01 
Brain region
Case Laminae SFC PC OC ITG PHG HC DG CB
A Size II/III 400 100 50 50 200 800 R R
V/VI 50 100 100 50 ≥ 1600
r II/III 0.42** 0.34** 0.03 0.40** 0.48** – – –
V/VI 0.31* –0.01 0.25* 0.09 0.07
B Size II/III ≥ 1600 800 200 800 50 50 R 50
V/VI 200 Reg 800
r II/III –0.01, 0.38** 0.19 0.27* 0.34** – – –
V/VI 0.15 0.29* –0.01
C Size II/III 200 ≥ 1600 100 50 ≥ 1600 – – 100
V/VI 100 200 800 ≥ 1600 50
r II/III 0.36** 0.40** 0.42** 0.25* 0.30* 0.42* – 0.10
V/VI 0.29* 0.31* 0.12 0.25* 0.27*
D Size II/III 50 400 100 100 200 50 – 800
V/VI 50 R ≥ 1600 50 R
r II/III 0.45** 0.39** 0.41** 0.44** 0.42** 0.65** – 0.62**
V/VI 0.33** 0.21 – 0.61** 0.48**
E Size II/III 100 100 100 800 50 – 50 100
V/VI 50 200 200 50
r II/III 0.47** 0.11 0.45** 0.30* 0.13 – 0.82** 0.12
V/VI 0.33** 0.50** 0.16 0.45**
F Size II/III R R 400 200 R – 50 400
V/VI 100 100 800 400 100
r II/III 0.52** 0.45** 0.40** 0.55** 0.32** – 0.14 0.38**
V/VI 0.44** 0.16 0.46** 0.35** 0.53**
G Size II/III 400 ≥ 1600 ≥ 1600 50 R 50 – 50
V/VI 800 50 800 100
r II/III 0.46** 0.24 0.61** 0.51** 0.35** 0.46** 0.24 0.65**
V/VI 0.50** 0.40** 0.29* 0.54** 0.28*
H Size II/III Reg R 400 200 400 50 R –
V/VI 400 200 ≥ 1600 200 100
r II/III 0.49** 0.36** 0.36** 0.49** 0.51** 0.30 0.44* –
V/VI 0.36* 0.10 0.58** 0.46** 0.21*
I Size II/III 400 100 ≥ 1600 200 50, – – > 1600
V/VI 400 50 R 100
r II/III 0.46** 0.33** 0.34** 0.41** 0.29* 0.21 – 0.11
V/VI 0.36** 0.45** 0.43** 0.18 0.42**
J Size II/III R Reg Reg 50 50 – 50 50
V/VI Reg R 50 Reg 200
r II/III 0.50** 0.40** 0.25* 0.70** 0.50** – 0.52** 0.24
V/VI 0.27* 0.31* 0.44** 0.66** 0.40**
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Discussion
The data suggest: 1) florid PrPsc deposits were
clustered around the larger diameter blood vessels,
the dimension of the clusters varying with brain
region and 2) the density of florid deposits declined
as a negative exponential function with distance from
a larger diameter blood vessel. Hence, the data are
consistent with the hypothesis that diffusion from
blood vessels is involved in the pathogenesis of the
florid deposits. 
There are several factors that could influence the
deposition of PrPsc around blood vessels. First, the dis-
tribution of PrPsc could represent an abortive attempt
to clear PrPsc from the brain via the cerebral circula-
tion as has been suggested for the removal of β-amy-
loid (Aβ) in Alzheimer’s disease (AD) [42]. Extracellu-
lar fluid is drained from the brain to the cervical
lymph nodes via the perivascular channels and there-
fore, PrPsc deposits around vessels could be attribut -
able to overloading of this system, i.e., to failed or
inhibited clearance. This process, however, should
affect both the florid and the diffuse PrPsc deposits
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Table III. Results of fitting a negative exponential model to the numbers of florid prion protein (PrPsc)
deposits at different distances from larger diameter (> 10 µm) blood vessels in various brain regions. 
SFC – superior frontal cortex, PC – parietal cortex, OC – occipital cortex, ITG – inferior temporal gyrus, PHG – parahippocampal gyrus, HC – hippocampus sec-
tors CA1/2, DG – dentate gyrus, CB – molecular layer of the cerebellum in 10 cases of variant Creutzfeldt-Jakob disease (vCJD)
Region Laminae Pearson’s ‘r’ Regression equation Probability
SFC II/III –0.92 Y = 2.24 – 0.0029X P < 0.001
SFC V/VI –0.97 Y = 4.65 – 0.0061X P < 0.001
PC II/III –0.94 Y = 5.57 – 0.0065X P < 0.001
PC V/VI –0.92 Y = 5.20 – 0.0088X P < 0.001
OC II/III –0.87 Y = 5.85 – 0.0097X P < 0.001
OC V/VI –0.91 Y = 4.28 – 0.0042X P < 0.001
ITG II/III –0.95 Y = 5.07 – 0.009X P < 0.001
ITG V/VI –0.95 Y = 4.98 – 0.009X P < 0.001
PHG II/III –0.92 Y = 5.65 – 0.011X P < 0.001
PHG V/VI –0.93 Y = 4.53 – 0.0061X P < 0.001
HC CA1/2 –0.96 Y = 3.11 – 0.014X P < 0.001
DG ML –0.64 Y = 2.41 – 0.0054X P > 0.05
CB ML –0.79 Y= 3.02 – 0.005X P < 0.01
vCJD pathology and blood vessels
Fig. 2. The density of florid prion protein (PrPsc)
deposits at different distances from large diame -
ter blood vessel profiles in laminae V/VI of the
frontal cortex in a case of variant Creutzfeldt-
Jakob disease (vCJD) (Fit to negative exponential
model r = –0.97, P < 0.001).
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but the latter do not exhibit any spatial relationship
with the microvessels [4]. In addition, as in AD, there
should be more resistance to drainage of Aβ in older
patients resulting in increased accumulation of amy-
loid close to the vessel. This is less likely to be a fac-
tor in vCJD as the majority of cases were young (mean
age 29 years). In addition, there was no correlation
between the cluster size of PrPsc deposits and age of
the patient at death.
Second, the distribution of the florid deposits
around blood vessels could reflect PrPsc deposition in
association with the endothelia of blood vessels or
adjacent cells. In experimental amylotrophic leu -
kospongiosus, for example, in which the disease agent
is PrP27-30, there were pathological changes in astro-
cytes adjacent to capillaries, their foot processes, and
in pericytes accompanied by PrPsc deposition in the
basement membrane and endothelium of altered
blood vessels coincident with disturbance of the blood
brain barrier [38]. Hence, if these cellular components
were involved exclusively in the formation of the florid
deposits it would result in a single ring of deposits
around affected vessels rather than a negative expo-
nential decline in density. Nevertheless, if smaller ca -
pillaries were also involved, these vessels could
decrease as a negative exponential function with dis-
tance from a larger blood vessel profile and result in
a similar distribution of the florid deposits. There is no
evidence, however, that the density of smaller capil-
laries decreases as a negative exponential function
with distance from the larger vessels [4] and more-
over, it is frequently the diffuse rather than the florid
deposits which show the closest association with
components of the smaller capillary vessel walls [4].
Third, a negative exponential distribution of florid
deposits could represent diffusion from blood vessels.
If diffusion is involved, then one explanation is
haematogenous spread of PrPsc into the brain 
[13-15,21,33] followed by diffusion from the brain
microvessels. Scrapie prion is one of the proteins able
to negotiate the blood-brain barrier early in the
course of the disease and even before overt damage
is present [34]. In addition, a dysfunctional blood-
cerebral spinal fluid barrier has been observed in 
6 out of 25 CJD patients [25] and could also encour-
age the leaking of PrPsc into the brain. Nevertheless,
neither the more abundant diffuse PrPsc deposits nor
the vacuoles show a spatial relationship with the
blood vessels in vCJD [4] which argues against the
pathology of vCJD originating by diffusion of prions
from blood vessels. In addition, in patients with CJD in
which there is evidence of amyloid in association with
vessel walls (capillary amyloid angiopathy), no PrPsc
has been observed in association with the vessels
[19]. Furthermore, PrPsc has not been detected in
blood plasma in human patients with CJD [15]
although it is possible that disease causing prions
may be present in blood at levels below those cur-
rently detectable. More recently, the presence of PrPsc
associated with white blood cells was investigated in
cases of sCJD [17]. No evidence of PrPsc was found in
purified granulocytes, monocytes, B cells, CD4(+)
T cells, CD8(+) T cells, natural killer cells, nonclassical
gamma delta T cells, or in platelets. Hence, if white
blood cells do harbor prion infectivity in vCJD, levels
are likely to be low and not sufficient to explain the
density of PrPsc around the vessels.
An alternative hypothesis is that as in sCJD and
AD [7,8], diffusion of proteins other than PrPsc may
influence the formation of the florid deposits. Dege -
neration of neurons and glial cells close to blood ves-
sels could compromise the integrity of the brain
microvasculature and increase the leakage of pro-
teins. Blood proteins, such as apolipoprotein E (apo E),
and amyloid-P have been recorded in association with
PrPsc deposits [1,26,35]. The most likely protein to
originate from blood vessels is amyloid-P, since the
liver is the only tissue of the body which exhibits its
mRNA [26]. Amyloid-P is a feature of all types of sys-
temic amyloid deposit and is evident in lesions in var-
ious diseases most notably in the Aβ deposits in AD
[26]. Plasma proteins such as amyloid-P could there-
fore diffuse from vessels and act as ‘molecular chap-
erones’ encouraging the aggregation of PrPsc mole-
cules to form florid deposits around blood vessels.
In conclusion, there are spatial correlations
between the florid-type PrPsc deposits and the cere-
bral microvessels in vCJD. The florid deposits are
aggregated around the larger diameter blood vessels
and their density declines exponentially with distance
from a prominent blood vessel consistent with diffu-
sion from blood vessels. Although there are small
numbers of vCJD cases in which blood transfusion
may have been the origin of the disease, it is less like-
ly that the spatial relationship observed in the pre -
sent study reflects the direct leakage of blood-borne
prions into the brain and, as in sCJD, more likely that
it reflects the leakage of proteins from the vessels
enhancing the aggregation of PrPsc in the vicinity of
the blood vessels. 
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